Search results
Showing 2191 to 2205 of 9039 results
In development Reference number: GID-TA10227 Expected publication date: TBC
In development Reference number: GID-TA10542 Expected publication date: TBC
MTX110 for untreated diffuse intrinsic pontine glioma [ID2695]
In development Reference number: GID-TA10573 Expected publication date: TBC
Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly [ID1596]
In development Reference number: GID-TA10497 Expected publication date: TBC
Talacotuzumab for untreated acute myeloid leukaemia [ID1262]
In development Reference number: GID-TA10249 Expected publication date: TBC
Lurbinectedin for treating advanced platinum-resistant ovarian cancer [ID1340]
In development Reference number: GID-TA10313 Expected publication date: TBC
In development Reference number: GID-TA10446 Expected publication date: TBC
Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]
In development Reference number: GID-TA11553 Expected publication date: TBC
Camlipixant for treating refractory or unexplained chronic cough [ID6722]
Awaiting development Reference number: GID-TA11707 Expected publication date: TBC
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]
In development Reference number: GID-TA11454 Expected publication date: 23 July 2026
Sutimlimab for treating haemolytic anaemia in people with cold agglutinin disease [ID6673]
Awaiting development Reference number: GID-TA11892 Expected publication date: TBC
In development Reference number: GID-TA11613 Expected publication date: TBC
Plozasiran for treating familial chylomicronaemia syndrome [ID6593]
In development Reference number: GID-TA11793 Expected publication date: 17 September 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
In development Reference number: GID-NG10434 Expected publication date: 27 July 2027
Awaiting development Reference number: GID-TA11953 Expected publication date: TBC